Editor-in-Chief: Dr. Lubna Naz
Editor: Dr. Taseer Ahmed Khan
ISSN-P: 2710-0286
ISSN-E: 2710-0294
Frequency: Biannual
Current DOI Prefix: 10.67773
Legacy DOI Prefix: 10.46568
Publisher: Department of Physiology, University of Karachi

Instructions for preparing and submitting manuscripts
These guidelines explain BioSight's editorial assessment, peer-review process, fees, publication ethics requirements, and manuscript preparation standards. Authors should read the complete document before submission and ensure that all required declarations and files are included.
All submissions are initially assessed by the editorial office for relevance to BioSight's aims and scope, completeness, originality, ethical compliance, and basic scholarly quality. Manuscripts that pass the initial assessment undergo double-blind peer review by two to three independent subject experts. The Editor-in-Chief makes the final publication decision based on the reviewers' reports, the authors' responses, and the journal's editorial standards.
Editorial decisions are independent of payment status, waiver requests, institutional affiliation, nationality, commercial considerations, and personal relationships.
BioSight does not charge a submission, screening, or peer-review fee. An article processing charge of PKR 5,000 is payable only after final editorial acceptance. Authors who are unable to pay may request a waiver by emailing biosight@uok.edu.pk after acceptance. Waiver requests are considered individually and confidentially and are not guaranteed. Payment or waiver decisions do not influence peer review or editorial decisions.
Authors retain copyright in their work and grant BioSight a non-exclusive right of first publication. Accepted articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits sharing and adaptation for any lawful purpose, including commercial use, provided appropriate credit is given, a link to the license is supplied, and any changes are indicated.
Authorship requires all of the following:
The corresponding author must ensure that all eligible contributors are listed, that no ineligible person is included, and that every author has approved the submission. The completed Authorship Declaration Form must accompany the manuscript. Contributors who do not meet the authorship criteria should be acknowledged with their permission.
Conflicts of interest. All authors must disclose financial, personal, professional, or institutional relationships that could influence the work. If none exist, state: 'The authors declare no conflicts of interest.'
Funding. Identify every source of financial or material support and describe the funder's role, if any, in study design, data collection, analysis, interpretation, manuscript preparation, or the decision to submit. If there was no specific funding, state: 'This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.'
Authors must disclose any use of generative artificial intelligence or AI-assisted technologies in preparing a manuscript. The disclosure should identify the tool and version where available, the purpose of use, and the sections or tasks for which it was used. AI tools cannot be listed as authors or cited as responsible sources. Authors remain fully responsible for the accuracy, originality, integrity, references, and ethical compliance of all submitted content. Routine spelling, grammar, reference-formatting, or basic language-correction tools generally do not require disclosure if they do not generate or substantially alter intellectual content.
The cover letter should:
The title page must include:
|
Article type |
Main text |
References |
Required structure |
|
Original article |
2,000 to 4,000 words |
Up to 25 |
Abstract, keywords, introduction, methods, results, discussion, conclusion, references, tables, and figures |
|
Review article |
Up to 5,000 words |
Up to 75 |
Abstract, keywords, logically organized review sections, conclusion, and references |
|
Editorial or brief communication |
Up to 2,000 words |
Up to 10 |
Abstract where appropriate, concise main text, conclusion, and references |
Original articles and review articles should include an abstract of no more than 250 words. Brief communications should include an abstract of no more than 150 words. Unless the article type requires otherwise, the abstract should concisely state the background, objective, methods, principal results, and conclusion. Provide three to six keywords that accurately describe the work.
Introduction. Provide relevant recent literature, identify the knowledge gap, and state the objective and rationale of the study.
Methods. Describe the study design, setting, participants or materials, sampling, procedures, interventions, equipment and manufacturers where relevant, outcomes, and analytical methods in enough detail to allow evaluation and replication.
Results. Present findings in a logical sequence without duplicating the same data extensively in text, tables, and figures. Report appropriate estimates, measures of uncertainty, and exact statistical results where relevant.
Discussion. Interpret the principal findings in relation to relevant evidence; explain plausible mechanisms; describe strengths and limitations; discuss implications; and identify appropriate directions for future research. A combined Results and Discussion section may be used when suitable.
Conclusion. State the conclusions supported by the findings without overstating causality, novelty, or generalizability.
Research involving humans must receive approval from an appropriate institutional or regional research ethics committee before the study begins and must comply with the applicable version of the Declaration of Helsinki and relevant local requirements. The Methods section must name the approving body and provide the approval or reference number. Authors must state how informed consent was obtained or explain a formally approved waiver. Identifiable personal information or images require specific consent for publication.
Research involving animals must receive prior approval from the appropriate animal ethics or institutional committee and follow applicable welfare standards. The approving body and approval number must be reported. If ethics approval was not required, authors should state the reason and cite the relevant policy or authority.
References must follow Vancouver style and be numbered consecutively in the order in which they first appear in the text. Verify every reference for accuracy and completeness. Use National Library of Medicine journal abbreviations where available; give the full title of a journal that has no standard abbreviation. List up to six authors; for more than six, list the first six followed by et al. Unaccepted manuscripts should not appear in the reference list; cite them in the text only with the source's written permission.
Journal article. Welsh J. Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys. 2012;523(1):107-14.
Book chapter. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr, Sodeman WA, editors. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974. p. 457-72.
Book. Anderson SC, Poulsen KB. Anderson's electronic atlas of hematology. Philadelphia: Lippincott Williams & Wilkins; 2002.
Submissions must be original and must not be under consideration by another journal. Authors must cite and acknowledge all reused words, data, images, ideas, and methods. Fabrication, falsification, plagiarism, duplicate publication, inappropriate image manipulation, and undisclosed competing interests are not acceptable. The journal may request raw data, ethics documentation, permissions, or other supporting records during evaluation or after publication. Concerns may lead to rejection, correction, retraction, or notification of relevant institutions as appropriate.
Authors must promptly notify the journal if they discover a material error in a submitted or published article. Requests for corrections will be evaluated according to the significance of the error and the integrity of the scholarly record. Authors and other stakeholders may submit a complaint or appeal with the manuscript or article details, a clear explanation, and supporting evidence. Appeals should be submitted within 30 days of the editorial decision. Complaints and appeals will be handled confidentially and will not result in retaliation.
Names, email addresses, and other personal information entered on the journal website will be used only for the stated purposes of the journal and will not be made available for unrelated purposes or to unrelated third parties, subject to legal, ethical, and publishing requirements.
BioSight
Department of Physiology, University of Karachi
Karachi 75270, Sindh, Pakistan
Email: biosight@uok.edu.pk
Website: https://biosight.org/index.php/bios
Editor-in-Chief: Dr. Lubna Naz
Editor: Dr. Taseer Ahmed Khan
ISSN-P: 2710-0286
ISSN-E: 2710-0294
Frequency: Biannual
Current DOI Prefix: 10.67773
Legacy DOI Prefix: 10.46568
Publisher: Department of Physiology, University of Karachi

Information for Reviewers
Click HERE to join as a Reviewer
Join ReviewerCredits and get CREDIT for Peer Reviewing
Enhance your skills as an Author, Reviewer, Editor.
Join these free courses:
Publons
AuthorAID
Editage
Website Designed and Developed by micrewsoft.com